Fe/Cu Bimetallic Nanozyme Co-Assembled with 177Lu and Tanshinone for Quadruple-Synergistic Tumor-Specific Therapy (Adv. Healthcare Mater. 9/2025)

IF 10 2区医学 Q1 ENGINEERING, BIOMEDICAL

Advanced Healthcare Materials Pub Date : 2025-04-07 DOI:10.1002/adhm.202570054

Xianyu Zhu, Lingling Zheng, Pengfei Zhao, Lingli Gao, Liang Wang, Jun Liu, Xu Yang, Hanrui Wei, Mingyu Zhang, Liang Yan, Han Lv, Jianhua Gong, Ji gang Yang, Zhenchang Wang

引用次数: 0

Abstract

Synergistic Therapy

Nanozyme carriers co-deliver natural products and radionuclides for quadruple-synergistic tumor-specific therapy. More details can be found in article 2402696 by Xianyu Zhu, Han Lv, Jianhua Gong, Ji gang Yang, and co-workers.

Abstract Image

查看原文本刊更多论文

协同治疗纳米酶载体可联合递送天然产物和放射性核素，实现四重协同肿瘤特异性治疗。更多详情，请参阅 Xianyu Zhu、Han Lv、Jianhua Gong、Ji gang Yang 及合作者撰写的文章 2402696。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Advanced Healthcare Materials 工程技术-生物材料

CiteScore

14.40

自引率

3.00%

发文量

600

审稿时长

1.8 months

期刊介绍： Advanced Healthcare Materials, a distinguished member of the esteemed Advanced portfolio, has been dedicated to disseminating cutting-edge research on materials, devices, and technologies for enhancing human well-being for over ten years. As a comprehensive journal, it encompasses a wide range of disciplines such as biomaterials, biointerfaces, nanomedicine and nanotechnology, tissue engineering, and regenerative medicine.